Literature DB >> 25214978

Five-year mortality and coronary heart disease development after normal coronary angiogram.

Jason T McMullan1, Christopher J Lindsell1, Andra L Blomkalns1.   

Abstract

BACKGROUND: Previous studies depict low cardiac event and mortality rates in patients with angiographically normal coronary arteries. These studies, however, are limited by small sample sizes, short follow-up intervals, and selection biases. This study was undertaken to determine the natural five-year course of a diverse cohort of subjects with documented normal coronary arteries with respect to coronary heart disease development, revascularization need, and all-cause mortality.
METHODS: Consecutive adult patients with angiographically normal coronary arteries were followed up for 5 years through medical record review. Patients with any degree of angiographic abnormality, including minimal luminal irregularity or non-critical stenosis, were excluded. Patients were not excluded based on age, co-morbidities (except cardiac transplant and structural heart disease), indication for angiogram, or initial hospitalization status.
RESULTS: Normal coronary arteries were found in 182 (31.3%) of 582 patients; 129 met all inclusion criteria. The mean age was (49.1±12.5) years; 47 (36.7%) were male and 75 (58.1%) were caucasian. The most common indication for angiography was cumulative risk factors (60.5%). Within 5 years of a normal angiogram, 13 of 129 patients died (10.1%; 95 CI 5.7%-16.9%). Six (40%; 95 CI 19.8% to 64.3%) of 15 patients undergoing repeat angiogram within five years developed new coronary heart disease, with one requiring revascularization. Of traditional risk factors of coronary heart disease, only diabetes was associated with a higher risk of death.
CONCLUSION: The natural five-year course of a diverse cohort of patients with documented normal coronary arteries suggests that there is significant risk for death and development of coronary heart disease.

Entities:  

Keywords:  Angiography; Coronary disease; Mortality; Prognosis

Year:  2011        PMID: 25214978      PMCID: PMC4129742          DOI: 10.5847/wjem.j.1920-8642.2011.01.004

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  34 in total

1.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

2.  Morbidity and use of medical resources in patients with chest pain and normal or near-normal coronary arteries.

Authors:  P Albertsson; H Emanuelsson; T Karlsson; C Lamm; W Sandén; G Lagerberg; J Herlitz
Journal:  Am J Cardiol       Date:  1997-02-01       Impact factor: 2.778

3.  Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X")

Authors:  D Opherk; G Schuler; K Wetterauer; J Manthey; F Schwarz; W Kübler
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

4.  Devolutionary pattern of coronary atherosclerosis in patients with angina pectoris. Coronary arteriographic studies.

Authors:  D Kimbiris; P Lavine; H Van Den Broek; M Najmi; W Likoff
Journal:  Am J Cardiol       Date:  1974-01       Impact factor: 2.778

5.  Long-term observations in patients with angina and normal coronary arteriograms.

Authors:  C R Bemiller; C J Pepine; A K Rogers
Journal:  Circulation       Date:  1973-01       Impact factor: 29.690

6.  The fate of women with normal coronary arteriograms and chest pain resembling angina pectoris.

Authors:  E B Waxler; D Kimbiris; L S Dreifus
Journal:  Am J Cardiol       Date:  1971-07       Impact factor: 2.778

7.  Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries.

Authors:  M N Papanicolaou; R M Califf; M A Hlatky; R A McKinnis; F E Harrell; D B Mark; B McCants; R A Rosati; K L Lee; D B Pryor
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

8.  Long-term follow-up of patients initially diagnosed with syndrome X.

Authors:  F Romeo; G M Rosano; E Martuscelli; L Lombardo; A Valente
Journal:  Am J Cardiol       Date:  1993-03-15       Impact factor: 2.778

9.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study.

Authors:  J C Kaski; G M Rosano; P Collins; P Nihoyannopoulos; A Maseri; P A Poole-Wilson
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

10.  Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging.

Authors:  E M Tuzcu; A C De Franco; M Goormastic; R E Hobbs; G Rincon; C Bott-Silverman; P McCarthy; R Stewart; E Mayer; S E Nissen
Journal:  J Am Coll Cardiol       Date:  1996-03-15       Impact factor: 24.094

View more
  3 in total

1.  Change in luminal diameter of the left internal thoracic artery anastomosed to the totally occluded left anterior descending coronary artery.

Authors:  Yochun Jung; Byoung Hee Ahn; Gwan Sic Kim; In Seok Jeong; Kyo Seon Lee; Sang Yun Song; Kook Joo Na; Sang Gi Oh
Journal:  J Cardiothorac Surg       Date:  2016-11-28       Impact factor: 1.637

2.  A retrospective cohort of coronary artery disease development after at least two angiograms in patients with normal coronary angiograms or mild coronary artery disease.

Authors:  Hassan Aghajani; Reza Moradi; Saeed Alizadeh; Bahareh Salekani; Behzad Garousi; Zahrasadat Rezaei; Hamidreza Soleimani
Journal:  Caspian J Intern Med       Date:  2021

3.  Guidelines for reasonable and appropriate care in the emergency department (GRACE): Recurrent, low-risk chest pain in the emergency department.

Authors:  Paul I Musey; Fernanda Bellolio; Suneel Upadhye; Anna Marie Chang; Deborah B Diercks; Michael Gottlieb; Erik P Hess; Michael C Kontos; Bryn E Mumma; Marc A Probst; John H Stahl; Jason P Stopyra; Jeffrey A Kline; Christopher R Carpenter
Journal:  Acad Emerg Med       Date:  2021-07-06       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.